Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France
The QLU-C10D is a fit-for-purpose ready-to-use PBM to estimate health state utilities of patients with cancer. This study adds to evidence that QLU-C10D has appropriate psychometric properties and appears to have higher statistical efficiency than generic PBMs in cancer.
Authors
- Madeleine King (ORCID: https://orcid.org/0000-0001-7192-2887)
- Simone Seyringer (ORCID: https://orcid.org/0000-0003-0689-9160)
- Micha J. Pilz (ORCID: https://orcid.org/0000-0003-4092-8797)
- Virginie Nerich (ORCID: https://orcid.org/0000-0002-0351-6040)
- Eva‐Maria Gamper (ORCID: https://orcid.org/0000-0002-1700-4054)
- Richard Norman (ORCID: https://orcid.org/0000-0002-3112-3893)
Institutions
- The University of Sydney (AU)
- Innsbruck Medical University (AT)
- Inserm (FR)
- Universität Innsbruck (AT)
- Curtin University (AU)
- Tirol Kliniken (AT)
- University Hospital Innsbruck (AT)
- Université de Franche-Comté (FR)
Publication Details
- Journal
- PharmacoEconomics
- Published
- 2025-04-27
- DOI
- https://doi.org/10.1007/s40273-025-01501-3
- Citations
- 2
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 6.26
Funders
- European Organisation for Research and Treatment of Cancer